News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
363,782 Results
Type
Article (14429)
Company Profile (115)
Press Release (349238)
Section
Business (112620)
Career Advice (456)
Deals (18611)
Drug Delivery (28)
Drug Development (31168)
Employer Resources (50)
FDA (8792)
Job Trends (7672)
News (172734)
Policy (12355)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1319)
Allergies (36)
Alliances (34770)
ALS (22)
Alzheimer's disease (499)
Antibody-drug conjugate (ADC) (60)
Approvals (8806)
Artificial intelligence (224)
Autoimmune disease (2)
Automation (11)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (87)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (108)
Cancer (923)
Cardiovascular disease (58)
Career advice (406)
Career pathing (8)
CAR-T (97)
Cell therapy (253)
Cervical cancer (8)
Clinical research (24397)
Collaboration (556)
Compensation (101)
Complete response letters (3)
COVID-19 (1146)
CRISPR (34)
C-suite (123)
Cystic fibrosis (47)
Data (864)
Decentralized trials (1)
Denatured (18)
Depression (14)
Diabetes (93)
Diagnostics (4889)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (69)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (18)
Earnings (38480)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51083)
Executive appointments (355)
FDA (9348)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (444)
Gene editing (80)
Generative AI (23)
Gene therapy (158)
GLP-1 (217)
Government (1232)
Grass and pollen (1)
Guidances (23)
Healthcare (9890)
Huntington's disease (5)
IgA nephropathy (9)
Immunology and inflammation (26)
Indications (11)
Infectious disease (1215)
Inflammatory bowel disease (59)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (55)
Interviews (51)
IPO (8003)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (114)
Leadership (3)
Legal (2520)
Liver cancer (34)
Lung cancer (113)
Lymphoma (55)
Machine learning (2)
Management (17)
Manufacturing (164)
MASH (14)
Medical device (11443)
Medtech (11448)
Mergers & acquisitions (10921)
Metabolic disorders (199)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (24)
Neuropsychiatric disorders (3)
Neuroscience (671)
NextGen: Class of 2025 (3535)
Non-profit (1519)
Northern California (1001)
Now hiring (8)
Obesity (85)
Opinion (75)
Ovarian cancer (39)
Pain (44)
Pancreatic cancer (37)
Parkinson's disease (61)
Partnered (10)
Patents (124)
Patient recruitment (48)
Peanut (25)
People (32651)
Pharmaceutical (16)
Phase I (9005)
Phase II (11011)
Phase III (7141)
Pipeline (426)
Podcasts (36)
Policy (26)
Postmarket research (501)
Preclinical (4053)
Press Release (66)
Prostate cancer (38)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (128)
Real estate (3358)
Recruiting (20)
Regulatory (9311)
Reports (18)
Research institute (1268)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (1)
RSV (20)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (16)
Southern California (1082)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2505)
State (2)
Stomach cancer (1)
Supply chain (22)
The Weekly (17)
United States (10571)
Vaccines (306)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (65)
Last 7 days (307)
Last 30 days (1489)
Last 365 days (17837)
2025 (3890)
2024 (18721)
2023 (22098)
2022 (30813)
2021 (32512)
2020 (30539)
2019 (25795)
2018 (19462)
2017 (18871)
2016 (17766)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (116)
Arkansas (10)
Asia (23981)
Australia (4177)
California (2622)
Canada (977)
China (217)
Colorado (149)
Connecticut (126)
Delaware (36)
Europe (48985)
Florida (433)
Georgia (128)
Idaho (33)
Illinois (256)
India (10)
Indiana (151)
Iowa (4)
Japan (94)
Kansas (79)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (429)
Massachusetts (1844)
Michigan (178)
Minnesota (238)
Mississippi (2)
Missouri (56)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (824)
New Mexico (16)
New York (779)
North Carolina (498)
North Dakota (7)
Northern California (1001)
Ohio (98)
Oklahoma (11)
Oregon (19)
Pennsylvania (537)
Puerto Rico (7)
Rhode Island (19)
South America (505)
South Carolina (15)
South Dakota (1)
Southern California (1082)
Tennessee (54)
Texas (424)
Utah (96)
Virginia (52)
Washington D.C. (11)
Washington State (307)
West Virginia (3)
Wisconsin (34)
363,782 Results for "dbv technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
February 26, 2025
·
7 min read
Business
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBV Technologies reported financial results for the first quarter 2024.
May 7, 2024
·
10 min read
DBV Technologies to Participate in Upcoming May 2024 Investor Conferences
DBV Technologies announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May.
May 9, 2024
·
2 min read
DBV Technologies Announces Results of its 2024 Combined General Meeting
DBV Technologies, a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting.
May 16, 2024
·
2 min read
Press Releases
DBV Technologies Announces Plan to Implement ADS Ratio Change
November 12, 2024
·
5 min read
Press Releases
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
January 9, 2025
·
11 min read
Press Releases
DBV Technologies Reports Third Quarter 2024 Financial Results
November 7, 2024
·
9 min read
Press Releases
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
March 24, 2025
·
16 min read
Press Releases
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
October 21, 2024
·
5 min read
DBV Technologies Announces Plan to Implement ADS Ratio Change
DBV Technologies announced plans to change the ratio of its American Depositary Shares to its ordinary shares, nominal value €0.10 per share, from the current ADS Ratio of one ADS to one-half of one ordinary share to a new ADS Ratio of one ADS to one ordinary share.
May 17, 2024
·
5 min read
1 of 36,379
Next
